Ready Made Platforms for Cell Therapy Success
Gain momentum with a proven path to accelerate cell therapy breakthroughs into clinical and commercial manufacturing.
Built for Progress:
Platform-Based Manufacturing
Our platform approach reduces up-front investment, minimizes risk, and shortens timelines, helping you to cut the cost of IND-enabling studies and move to clinical production, faster.
Backed by years of cell therapy manufacturing experience, our standardized processes are optimized for speed, quality, and compliance - while maintaining the flexibility for your unique product.

Typical Timeline for Clinical Readiness: 12+ Months




Made Scientific's Ready Made Platform: Six Months
Transfer




Cut Your Development Timeline Significantly
Traditional cell therapy process development can take 12+ months to reach clinical readiness. Made Scientific's Ready Made Platforms can reduce this timeline to as little as six months.
- Reduce process development and scale-up timelines by up to 70%
- De-risk manufacturing with proven processes and analytical methods
- Access pre-validated equipment, documentation, and manufacturing workflows
- Transition smoothly from academic settings to GMP production
- Leverage platform processes tailored to specific cell types, including T cells, NK cells, MSCs, etc.
- Implement phase-appropriate quality systems from day one
The Ready Made Advantage -
Validated, Tested, Proven
Choose our Ready Made Platforms and gain access to everything you need for seamless implementation: established processes, expertise, equipment, and ready-to-use documentation.
Pre-Existing Master Batch Records
Ready to customize to your specific product
Established SOPs
Comprehensive set of standard operating procedures
Validated Analytical Methods
Validated test methods for product characterization and release
Expert Personnel
Experienced clinical manufacturing and quality teams, trained in-house and ready to execute
Completed Aseptic Validation
Media fills and aseptic processing validation
Proven and Reliable Supply Chain
Qualified vendors and pre-sourced critical materials
Phase Appropriate Quality System
Risk-based quality systems aligned with every development phase
Fit-for-Purpose Facilities and Equipment
Manufacturing suites and equipment qualified for cell therapy production

The Proven Path to IND-Ready Manufacturing Starts Here
Want to reduce your development time by 70%?
Reach patients in as little as six months with the Ready Made Platforms.
See how Made Scientific helps cell therapy developers go from kick-off to patient dosing faster, smarter, and with less risk.
Specialized Platforms for Multiple Cell Types
Made Scientific offers optimized platform processes for various cell therapy modalities.
T Cell Platform
- Standardized processes for T Cell isolation, activation, and expansion
- Optimized viral and non-viral genetic modification methods
- Scalable manufacturing from small clinical batches to commercial quantities
- Comprehensive QC testing package specific to T Cell products
NK Cell Platform
- Proven feeder cell systems for robust NK Cell expansion
- Optimized cytokine cocktails for enhanced function and persistence
- Specialized cryopreservation methods for improved post-thaw recovery
- Custom potency assays correlated with clinical outcomes
MSC Platform
- Standardized isolation and expansion processes from multiple tissue sources
- Scaled clinical manufacturing in various bioreactor systems
- Characterization package aligned with ISCT criteria
- Specialized formulation for improved stability
Other Available Platforms
- Regulatory T Cell (Treg) Platform
- iPSC-Derived Cell Platform
- Tumor-Infiltrating Lymphocyte (TIL) Platform
- Custom Platform Development

Get Started Today
Connect with our team to explore the right Ready Made Platform for your needs and get a tailored plan to reach the clinic, and patients, faster.